VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (1176)	6/13/1997 12:11:00 AM
From: Vector1	of 9719

Max, when you compare the Coulter(Bexxar) results with ONCOLYM(techniclone) you begin to see how impressive the Coulter resuls are. Oncolym has had a 56% response rate according to their press release. Response can mean anything from complete remission to stopping or slowing progression. Almost half the BExxar patients had COMPLETE remisions with substantial tumor shrinkage in all with one patient relapsing. These are unusually strong resuls. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next